{"doi":"10.1016/j.contraception.2025.111212","title":"Transgender, nonbinary, and gender expansive experiences with telehealth medication abortion and implications for health equity in the United States","abstract":"OBJECTIVES: Transgender, nonbinary, and gender-expansive patients need abortion care. However, little is known about trans and gender expansive patients' experiences with telehealth abortion care, a growing model of abortion service post-Dobbs. STUDY DESIGN: We conducted 15 in-depth interviews with trans and gender expansive patients of three US virtual abortion clinics who obtained telehealth abortion care between April 2021 and May 2024. Interviews were transcribed and analyzed abductively using NVivo. RESULTS: Telehealth abortion reduced barriers for trans and gender expansive patients. Many interviewees appreciated the ability to avoid entering an abortion clinic, a space typically associated with \"women's health.\" Telehealth allowed patients to circumvent barriers to care such as potential gender discrimination or uncomfortable gender-related interactions. Additionally, patients reported an increased sense of privacy due to being able to report their chosen name and/or pronouns on intake forms, or not disclose their gender identity altogether. As a result, patients were able to cultivate positive relationships with providers. CONCLUSION: Telehealth abortion care is highly acceptable and beneficial for trans and gender expansive patients, as they benefit from an at-home experience coupled with reduced gender discrimination. Findings can help direct gender-affirming abortion care in person and in virtual clinics. IMPLICATIONS: Healthcare providers should prioritize delivery of care models that allow patients to either disclose their chosen name and pronouns or keep their gender identity and presentation private. As part of this, a telehealth model is an integral element of trans-inclusive abortion provision.","journal":"Contraception","year":2025,"id":547103,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9463,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1439121,"name":"Stef M. Shuster","orcid":"0000-0003-1970-5257","position":1,"is_corresponding":false},{"id":851679,"name":"Leah R. Koenig","orcid":"0000-0002-4982-8672","position":2,"is_corresponding":false},{"id":1031855,"name":"Jennifer Ko","orcid":"0009-0002-9989-1386","position":3,"is_corresponding":false},{"id":322346,"name":"Ushma D. Upadhyay","orcid":"0000-0002-2731-2157","position":4,"is_corresponding":false},{"id":694930,"name":"Andréa Becker","orcid":"0000-0002-7948-4276","position":0,"is_corresponding":true}],"reference_count":13,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:53:36.567932Z","pmid":"40983240","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}